Teva Pharmaceuticals USA Issues Statement on Affordable Medicines Utilization Act of 2011

NORTH WALES, Pa.--(BUSINESS WIRE)-- Teva commends Senators Scott Brown, Ron Wyden and John McCain for introducing the Affordable Medicines Utilization Act of 2011. As the largest provider of generic pharmaceuticals in the United States, Teva has been and continues to be committed to providing patients with access to the life-saving medicines they need. This legislation will encourage States to increase access to high-quality, low-cost pharmaceuticals for their Medicaid populations. At a time when State government officials are struggling to close their budget shortfalls, improving access to FDA approved generic medicines will help lower their health care costs while maintaining access to care.



CONTACT:

Teva Pharmaceuticals
Denise Bradley, 215-591-8974
[email protected]

KEYWORDS:   United States  North America  Pennsylvania

INDUSTRY KEYWORDS:   Health  Public Policy/Government  Healthcare Reform  Pharmaceutical

MEDIA:

Suggested Articles

Merck's Keytruda has new long-term survival results that the drugmaker hopes will help bolster its position in first-line NSCLC.

Last year at ESMO, AZ and Merck showed Lynparza topped its rivals at fending off prostate cancer. Now, Lynparza has helped patients live longer, too.

Merck and Eisai are trying to take their Keytruda-Lenvima combo into additional cancers, and new data provide a glimpse of where it might go next.